Cargando…
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells
Adriamycin-based combination chemotherapy is the standard first-line treatment for osteosarcoma, but tumor recurrence and metastasis occurs in most cases. Recent evidence suggests that microenvironmental stress such as chemotherapy can lead to the enrichment of cancer stem cells (CSCs), which result...
Autores principales: | Li, Yangling, Xian, Miao, Yang, Bo, Ying, Meidan, He, Qiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470096/ https://www.ncbi.nlm.nih.gov/pubmed/28552603 http://dx.doi.org/10.1016/j.stemcr.2017.04.025 |
Ejemplares similares
-
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells
por: Li, Yangling, et al.
Publicado: (2020) -
MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4
por: Wang, Guang-Chao, et al.
Publicado: (2016) -
The HER2 inhibitor TAK165 Sensitizes Human Acute Myeloid Leukemia Cells to Retinoic Acid-Induced Myeloid Differentiation by activating MEK/ERK mediated RARα/STAT1 axis
por: Shao, Xuejing, et al.
Publicado: (2016) -
Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
por: Zhu, Hong, et al.
Publicado: (2014) -
Human osteosarcoma CD49f(−)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity
por: Ying, Meidan, et al.
Publicado: (2012)